Virtual screening and lead optimization of Desmostachya bipinnata-derived FGFR inhibitors for oral squamous cell carcinoma management
Background: Oral cancer remains a major global health challenge with limited therapeutic options, highlighting the need for novel treatments. Phytochemicals derived from Desmostachya bipinnata (Db), a plant used in traditional Chinese medicine for its anti-inflammatory and analgesic properties, have...
Saved in:
Main Authors: | Nitya Krishnasamy (Author), Ramya Ramadoss (Author), Swarnalakshmi Raman (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In - Vitro activity of Desmostachya bipinnata (L.) Stapf successive extracts against Helicobacter pylori clinical isolates
by: Nermin H. Ibrahim, et al.
Published: (2018) -
Effect of FGFR alteration on prognosis in 1963 urothelial carcinoma patients with immune checkpoint inhibitors: Implying combination of FGFR inhibitor and immunotherapy for FGFR-altered urothelial carcinoma
by: Yuxuan Song, et al.
Published: (2024) -
Mutational Status of FGFR3 in Oral Squamous Cell Carcinoma.
by: P Motahhary, et al.
Published: (2012) -
Salivary stimulatory effect of novel low level transcutaneous electro neurostimulator in geriatric patients with xerostomia
by: Ramya Ramadoss, et al.
Published: (2023) -
Prediction of biological activity of spiroquinazolone derivatives as protein kinase inhibitors FGFR1 and CK2
by: O. K. Farat, et al.
Published: (2020)